Rapamune

Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.🇺🇸 United States

FDA Page

Effective Date: Jan 22, 2024
Approval ID: 3275b824-3f82-4151-2ab2-0036a9ba0acc
Products: 4 registered
Version: 70

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use RAPAMUNE safely and effectively. See full prescribing information for RAPAMUNE. RAPAMUNE (sirolimus) oral solution RAPAMUNE (sirolimus) tablets, for oral use Initial U.S. Approval: 1999

Quick Stats

Total Products4

Labelers2

Label Sections31

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.